{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:43:13Z","timestamp":1790815393045,"version":"4.1.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1038\/ajg.2016.223","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T08:02:49Z","timestamp":1465286569000},"page":"1165-1176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome"],"prefix":"10.14309","volume":"111","author":[{"given":"Sean M P","family":"Bennet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annikka","family":"Polster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"T\u00f6rnblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Isaksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Capronnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Tessier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Le Nev\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Simr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"\u00d6hman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210306","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R2-23-20210306","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1053\/gast.2002.37095","article-title":"AGA technical review on irritable bowel syndrome.","volume":"123","author":"Drossman","year":"2002","journal-title":"Gastroenterology"},{"key":"R4-23-20210306","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/nmo.12365","article-title":"Markers for visceral hypersensitivity in patients with irritable bowel syndrome.","volume":"26","author":"Ludidi","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"R5-23-20210306","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.33579","article-title":"Activation of the mucosal immune system in irritable bowel syndrome.","volume":"122","author":"Chadwick","year":"2002","journal-title":"Gastroenterology"},{"key":"R6-23-20210306","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ajg.2013.120","article-title":"Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?","volume":"108","author":"Hughes","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R7-23-20210306","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ajg.2008.86","article-title":"Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.","volume":"104","author":"Langhorst","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R8-23-20210306","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2007.01.046","article-title":"Immune activation in patients with irritable bowel syndrome.","volume":"132","author":"Liebregts","year":"2007","journal-title":"Gastroenterology"},{"key":"R9-23-20210306","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ajg.2009.116","article-title":"T-cell activation in patients with irritable bowel syndrome.","volume":"104","author":"Ohman","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R10-23-20210306","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1440-1746.2005.04143.x","article-title":"Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.","volume":"21","author":"Park","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"R11-23-20210306","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ajg.2008.94","article-title":"Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.","volume":"104","author":"Cremon","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R12-23-20210306","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1111\/j.1572-0241.2008.01871.x","article-title":"Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors.","volume":"103","author":"Dinan","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R13-23-20210306","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1469-8986.2012.01371.x","article-title":"Circulating cytokine signatures in healthy medical students exposed to academic examination stress.","volume":"49","author":"Kamezaki","year":"2012","journal-title":"Psychophysiology"},{"key":"R14-23-20210306","doi-asserted-by":"crossref","first-page":"e0134836","DOI":"10.1371\/journal.pone.0134836","article-title":"Cytokine response after stimulation with key commensal bacteria differ in post-infectious irritable bowel syndrome (PI-IBS) patients compared to healthy controls.","volume":"10","author":"Sundin","year":"2015","journal-title":"PLoS One"},{"key":"R15-23-20210306","first-page":"711","article-title":"Irritable bowel syndrome immune hypothesis. Part two: the role of cytokines.","volume":"102","author":"Ortiz-Lucas","year":"2010","journal-title":"Rev Esp Enferm Dig"},{"key":"R16-23-20210306","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cyto.2011.11.019","article-title":"Cytokines and irritable bowel syndrome: Where do we stand?","volume":"57","author":"Bashashati","year":"2012","journal-title":"Cytokine"},{"key":"R17-23-20210306","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/nmo.12358","article-title":"Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis.","volume":"26","author":"Bashashati","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"R18-23-20210306","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.gastro.2005.11.033","article-title":"Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?","volume":"130","author":"Dinan","year":"2006","journal-title":"Gastroenterology"},{"key":"R19-23-20210306","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/ajg.2010.159","article-title":"Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity.","volume":"105","author":"Scully","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R20-23-20210306","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1365-2036.2011.04624.x","article-title":"Altered peripheral toll-like receptor responses in the irritable bowel syndrome.","volume":"33","author":"McKernan","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R21-23-20210306","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/MPG.0b013e3181fd9816","article-title":"Decreased interleukin-10 secretion by peripheral blood mononuclear cells in children with irritable bowel syndrome.","volume":"52","author":"Hua","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R22-23-20210306","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ajg.2011.423","article-title":"Serum and colonic mucosal immune markers in irritable bowel syndrome.","volume":"107","author":"Chang","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R23-23-20210306","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1080\/00365520802276127","article-title":"Mucosal cytokine imbalance in irritable bowel syndrome.","volume":"43","author":"Macsharry","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"R24-23-20210306","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/00365521.2012.666672","article-title":"Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.","volume":"47","author":"De Silva","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"R25-23-20210306","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4 regulatory t cells for immunologic self-tolerance and negative control of immune responses.","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"R26-23-20210306","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2982.2006.00878.x","article-title":"CD4CD25 regulatory T cells in irritable bowel syndrome patients.","volume":"19","author":"Holmen","year":"2007","journal-title":"Neurogastroenterol Motil"},{"key":"R27-23-20210306","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ajg.2012.54","article-title":"Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?","volume":"107","author":"Braak","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R28-23-20210306","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression.","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol"},{"key":"R29-23-20210306","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbi.2010.11.010","article-title":"Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.","volume":"25","author":"Elsenbruch","year":"2011","journal-title":"Brain Behav Immun"},{"key":"R30-23-20210306","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7869\/tg.2012.66","article-title":"Pro-inflammatory and anti-inflammatory cytokine response in diarrhoea-predominant irritable bowel syndrome patients.","volume":"33","author":"Rana","year":"2012","journal-title":"Trop Gastroenterol"},{"key":"R31-23-20210306","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1113\/jphysiol.2014.279968","article-title":"Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.","volume":"592","author":"Buckley","year":"2014","journal-title":"J Physiol"},{"key":"R32-23-20210306","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders.","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"R33-23-20210306","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00195769","article-title":"Collagenous, microscopic and lymphocytic colitis. An evolving concept.","volume":"424","author":"Bogomoletz","year":"1994","journal-title":"Virchows Arch"},{"key":"R34-23-20210306","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1572-0241.2003.07542.x","article-title":"Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome.","volume":"98","author":"Dunlop","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R35-23-20210306","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2982.2005.00709.x","article-title":"Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility.","volume":"17","author":"Cremonini","year":"2005","journal-title":"Neurogastroenterol Motil"},{"key":"R36-23-20210306","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ajg.2012.5","article-title":"Colonic transit time and IBS symptoms: whats the link?","volume":"107","author":"Tornblom","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R37-23-20210306","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale.","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"R38-23-20210306","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00006842-200203000-00008","article-title":"The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms.","volume":"64","author":"Kroenke","year":"2002","journal-title":"Psychosom Med"},{"key":"R39-23-20210306","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress.","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"R40-23-20210306","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-230X-12-91","article-title":"Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome.","volume":"12","author":"Chen","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"R42-23-20210306","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/cyto.1997.0290","article-title":"The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety.","volume":"10","author":"Maes","year":"1998","journal-title":"Cytokine"},{"key":"R43-23-20210306","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/bega.1999.0037","article-title":"Putative inflammatory and immunological mechanisms in functional bowel disorders.","volume":"13","author":"Collins","year":"1999","journal-title":"Baillieres Best Pract Res Clin Gastroenterol"},{"key":"R44-23-20210306","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ajg.2011.484","article-title":"Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico.","volume":"107","author":"Schmulson","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R45-23-20210306","first-page":"781","article-title":"The expression of mucosal IL-1beta, TNFalpha and serotonin transporter in chronic visceral hypersensitivity rats.","volume":"49","author":"Chi","year":"2010","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"R46-23-20210306","doi-asserted-by":"crossref","first-page":"G781","DOI":"10.1152\/ajpgi.2000.279.4.G781","article-title":"Systemic lipopolysaccharide influences rectal sensitivity in rats: role of mast cells, cytokines, and vagus nerve.","volume":"279","author":"Coelho","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R47-23-20210306","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/gutjnl-2014-308188","article-title":"Randomised controlled trial of mesalazine in IBS.","volume":"65","author":"Barbara","year":"2016","journal-title":"Gut"},{"key":"R48-23-20210306","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gutjnl-2015-309122","article-title":"A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D).","volume":"65","author":"Lam","year":"2016","journal-title":"Gut"},{"key":"R49-23-20210306","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S1542-3565(05)00410-6","article-title":"A controlled study of colonic immune activity and beta7 blood T lymphocytes in patients with irritable bowel syndrome.","volume":"3","author":"Ohman","year":"2005","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2016223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016223","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2016223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201608000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:12:53Z","timestamp":1786547573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201608000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2016.223","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}